Skip to main content
. 2020 May 11;25(7):e1051–e1059. doi: 10.1634/theoncologist.2020-0063

Table 4.

Literature overview: Oncological and obstetrical outcomes after NACT and VRT

Study Planned NACT+VRT Underwent NACT+VRT Adjuvant treatment Median/mean FU (months) Fertility preservation n (%) Recurrences n (%) Deaths Attempted pregnancies Pregnancies Live births
Maneo 2008a 28 21 16 2 (RT) 69 100% 0 0 9/16

10 in 6 patients

9
Plante 2011 6, 22 4 4 0 95 4 (100) 0 0 3/4

4

1 preterm

2 term

Singh 2011 23 1 1 1 (CT) 14 1 (100) 0 0
Marchiolè 2018 20 19 19

1 (RT)

2 women refused adjuvant treatment

63 17 (89) 2/19 (10) 0 6/19 8 3 term
Wang 2013 24 2 2 0 84 2 (100) 0 0 0 n/a n/a
Lanowska 2014 21 20 18 1 (RT) 23 17 (85) 1 (5.5) 0 7/7

6

1 ongoing

2 preterm

2 term

Robova 2014 9 28 20 0 42 20 (71) 4/20 (20) 2/20 (10) 12/20

10

In 8 women:

6 term

4 preterm

Hauerberg 2015 25 1 1 0 68 1 (100) 0 0
Our report 2019 18 14 0 49.7 14 (18) 3/14 (21) 0 6/4 6 3 live births

Abbreviations: —, unknown; CT, chemotherapy; FU, follow‐up; n/a, not applicable; NACT, neoadjuvant chemotherapy; RT, radiotherapy; VRT, vaginal radical trachelectomy.

a

Cold knife conization, max 3 cm diameter of tumor before treatment.